ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 166 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,223 | -29.5% | 195,125 | 0.0% | 0.03% | -25.6% |
| Q2 2023 | $271,224 | -12.6% | 195,125 | 0.0% | 0.04% | -18.8% |
| Q1 2023 | $310,249 | +391.8% | 195,125 | +1827.2% | 0.05% | +380.0% |
| Q4 2022 | $63,079 | -7.2% | 10,125 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $68,000 | +4.6% | 10,125 | 0.0% | 0.01% | +9.1% |
| Q2 2022 | $65,000 | +38.3% | 10,125 | 0.0% | 0.01% | +83.3% |
| Q1 2022 | $47,000 | -7.8% | 10,125 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $51,000 | -58.2% | 10,125 | 0.0% | 0.01% | -64.7% |
| Q3 2021 | $122,000 | -43.0% | 10,125 | 0.0% | 0.02% | -39.3% |
| Q2 2021 | $214,000 | -24.6% | 10,125 | 0.0% | 0.03% | -30.0% |
| Q1 2021 | $284,000 | +8.0% | 10,125 | 0.0% | 0.04% | -2.4% |
| Q4 2020 | $263,000 | -30.1% | 10,125 | 0.0% | 0.04% | -39.7% |
| Q3 2020 | $376,000 | -27.6% | 10,125 | 0.0% | 0.07% | -30.6% |
| Q2 2020 | $519,000 | +62.2% | 10,125 | 0.0% | 0.10% | +34.2% |
| Q1 2020 | $320,000 | -46.9% | 10,125 | 0.0% | 0.07% | -28.4% |
| Q4 2019 | $603,000 | +62.1% | 10,125 | 0.0% | 0.10% | +50.0% |
| Q3 2019 | $372,000 | -21.0% | 10,125 | 0.0% | 0.07% | -19.0% |
| Q2 2019 | $471,000 | +16.0% | 10,125 | 0.0% | 0.08% | +13.5% |
| Q1 2019 | $406,000 | -12.9% | 10,125 | 0.0% | 0.07% | -23.7% |
| Q4 2018 | $466,000 | -5.7% | 10,125 | -9.0% | 0.10% | +15.5% |
| Q3 2018 | $494,000 | -16.6% | 11,125 | -26.4% | 0.08% | -20.8% |
| Q2 2018 | $592,000 | -26.5% | 15,125 | +36.0% | 0.11% | -25.9% |
| Q1 2018 | $805,000 | -6.8% | 11,125 | -15.2% | 0.14% | -4.0% |
| Q4 2017 | $864,000 | +31.3% | 13,125 | 0.0% | 0.15% | +25.2% |
| Q3 2017 | $658,000 | – | 13,125 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |